|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM35923108X |
| 003 |
DE-627 |
| 005 |
20240802232424.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2023.109689
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1489.xml
|
| 035 |
|
|
|a (DE-627)NLM35923108X
|
| 035 |
|
|
|a (NLM)37422057
|
| 035 |
|
|
|a (PII)S1521-6616(23)00452-7
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Garcia-Carmona, Yolanda
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a TACI and endogenous APRIL in B cell maturation
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 29.09.2023
|
| 500 |
|
|
|a Date Revised 02.08.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a While many of the genes and molecular pathways in the germinal center B cell response which initiate protective antibody production are known, the contributions of individual molecular players in terminal B cell differentiation remain unclear. We have previously investigated how mutations in TACI gene, noted in about 10% of patients with common variable immunodeficiency, impair B cell differentiation and often, lead to lymphoid hyperplasia and autoimmunity. Unlike mouse B cells, human B cells express TACI-L (Long) and TACI-S (Short) isoforms, but only TACI-S promotes terminal B cell differentiation into plasma cells. Here we show that the expression of intracellular TACI-S increases with B cell activation, and colocalizes with BCMA and their ligand, APRIL. We show that the loss of APRIL impairs isotype class switch and leads to distinct metabolic and transcriptional changes. Our studies suggest that intracellular TACI-S and APRIL along with BCMA direct long-term PC differentiation and survival
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a A proliferation inducing ligand (APRIL)
|
| 650 |
|
4 |
|a BCMA (B cell maturation antigen)
|
| 650 |
|
4 |
|a Plasma cell
|
| 650 |
|
4 |
|a TACI (transmembrane activator and CAML interactor)
|
| 650 |
|
7 |
|a TNFSF13 protein, human
|2 NLM
|
| 650 |
|
7 |
|a B-Cell Maturation Antigen
|2 NLM
|
| 650 |
|
7 |
|a Transmembrane Activator and CAML Interactor Protein
|2 NLM
|
| 650 |
|
7 |
|a Tumor Necrosis Factor Ligand Superfamily Member 13
|2 NLM
|
| 650 |
|
7 |
|a B-Cell Activating Factor
|2 NLM
|
| 700 |
1 |
|
|a Fribourg, Miguel
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sowa, Allison
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Cerutti, Andrea
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Cunningham-Rundles, Charlotte
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 253(2023) vom: 09. Aug., Seite 109689
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:253
|g year:2023
|g day:09
|g month:08
|g pages:109689
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109689
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 253
|j 2023
|b 09
|c 08
|h 109689
|